Metropolitan Life Insurance Company (MetLife)’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-39,304	Closed	-$495K	–	2807
2013 Q3	$495K	Hold	39,304	–	–	﹤0.01%	1757
2013 Q2	$569K	Buy	+39,304	New	+$572K	﹤0.01%	1614

Metropolitan Life Insurance Company (MetLife)'s OPTR Position: Q4 2013 in Review

Metropolitan Life Insurance Company (MetLife) sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 39,304 shares — an estimated $495K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $569K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

Metropolitan Life Insurance Company (MetLife) reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 39,304 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $495K.
Metropolitan Life Insurance Company (MetLife) first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
Metropolitan Life Insurance Company (MetLife)'s OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $569K in Q2 2013.
0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2013, filed 30 Jan 2014.